Faria M. Siddiqui
Massachusetts General Hospital(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, RNA modifications and cancer, Cancer therapeutics and mechanisms, Cell death mechanisms and regulation
Most-Cited Works
- → Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition(2016)978 cited
- → Therapy-induced APOBEC3A drives evolution of persistent cancer cells(2023)135 cited
- → Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS -Mutant Non–Small Cell Lung Cancer(2018)91 cited
- → Disruption of Endocytosis with the Dynamin Mutantshibirets1Suppresses Seizures inDrosophila(2015)27 cited
- → APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer(2021)18 cited
- → Abstract 877: Evolution of resistance to EGFR inhibition from drug tolerant cancer cells(2016)1 cited
- → Data from Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in <i>KRAS</i>-Mutant Non–Small Cell Lung Cancer(2023)1 cited
- → Abstract B53: Dynamic evolution of resistance to EGFR blockade from drug tolerant cancer cells(2015)
- → Supplementary Data from Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in <i>KRAS</i>-Mutant Non–Small Cell Lung Cancer(2023)